OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 Update
Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 5, pp. 899-912
Open Access | Times Cited: 12
Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 5, pp. 899-912
Open Access | Times Cited: 12
Showing 12 citing articles:
NLRP3 inflammasome signalling in Alzheimer's disease
Róisín M. McManus, Eicke Latz
Neuropharmacology (2024) Vol. 252, pp. 109941-109941
Open Access | Times Cited: 16
Róisín M. McManus, Eicke Latz
Neuropharmacology (2024) Vol. 252, pp. 109941-109941
Open Access | Times Cited: 16
Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Shuyang Xie, Hualong Liu, Ke Yang, et al.
Nano Biomedicine and Engineering (2025)
Open Access | Times Cited: 1
Shuyang Xie, Hualong Liu, Ke Yang, et al.
Nano Biomedicine and Engineering (2025)
Open Access | Times Cited: 1
Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
How to advance the pharmacological management of cognitive impairment in Parkinson's disease
Carla Abdelnour, Lucy L. Gibson, Lucia Batzu, et al.
Journal of Parkinson s Disease (2025)
Open Access
Carla Abdelnour, Lucy L. Gibson, Lucia Batzu, et al.
Journal of Parkinson s Disease (2025)
Open Access
Precision Medicine in Parkinson’s Disease
Gadi Maayan Eshed, Roy N. Alcalay
Neurologic Clinics (2025)
Closed Access
Gadi Maayan Eshed, Roy N. Alcalay
Neurologic Clinics (2025)
Closed Access
Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review
Alexandra K. Mitchell, Rebecca R. Bliss, Frank Church
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1241-1241
Open Access | Times Cited: 2
Alexandra K. Mitchell, Rebecca R. Bliss, Frank Church
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1241-1241
Open Access | Times Cited: 2
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
Jinsong Xue, Keju Tao, Weijia Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1641-1641
Open Access | Times Cited: 2
Jinsong Xue, Keju Tao, Weijia Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1641-1641
Open Access | Times Cited: 2
α-Synuclein pathology as a target in neurodegenerative diseases
Hye-Jin Park, Tae‐In Kam, Valina L. Dawson, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 2
Hye-Jin Park, Tae‐In Kam, Valina L. Dawson, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 2
Automatic collaborative learning for drug repositioning
Yi Wang, Yajie Meng, Chang Sheng Zhou, et al.
Engineering Applications of Artificial Intelligence (2024) Vol. 139, pp. 109653-109653
Closed Access | Times Cited: 1
Yi Wang, Yajie Meng, Chang Sheng Zhou, et al.
Engineering Applications of Artificial Intelligence (2024) Vol. 139, pp. 109653-109653
Closed Access | Times Cited: 1
Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Hyemi Eo, Sehwan Kim, Un Ju Jung, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7243-7243
Open Access | Times Cited: 1
Hyemi Eo, Sehwan Kim, Un Ju Jung, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7243-7243
Open Access | Times Cited: 1
Network analysis of α-synuclein pathology progression reveals p21-activated kinases as regulators of vulnerability
Naman Vatsa, Julia K. Brynildsen, Thomas Goralski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Naman Vatsa, Julia K. Brynildsen, Thomas Goralski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Protein aggregation in health and disease: A looking glass of two faces
Guilherme C. de Andrade, Michelle F. Mota, Dinarte N. Moreira-Ferreira, et al.
Advances in protein chemistry and structural biology (2024)
Closed Access
Guilherme C. de Andrade, Michelle F. Mota, Dinarte N. Moreira-Ferreira, et al.
Advances in protein chemistry and structural biology (2024)
Closed Access
